236 related articles for article (PubMed ID: 19585648)
21. Tripartite Motif-Containing Protein 65 (TRIM65) Inhibits Hepatitis B Virus Transcription.
Shen S; Yan R; Xie Z; Yu X; Liang H; You Q; Zhang H; Hou J; Zhang X; Liu Y; Sun J; Guo H
Viruses; 2024 May; 16(6):. PubMed ID: 38932182
[TBL] [Abstract][Full Text] [Related]
22. Tripartite Motif-Containing 22 Gene -364T/C Polymorphism Associated With Hepatitis B Virus Infection in Chinese Han Population.
Zhao N; Wang XL; Gu QH; Huang F; Zheng W; Li ZW
Hepat Mon; 2014 Jan; 14(1):e12110. PubMed ID: 24596578
[TBL] [Abstract][Full Text] [Related]
23. Dynamic localization of tripartite motif-containing 22 in nuclear and nucleolar bodies.
Sivaramakrishnan G; Sun Y; Tan SK; Lin VC
Exp Cell Res; 2009 May; 315(8):1521-32. PubMed ID: 19331816
[TBL] [Abstract][Full Text] [Related]
24. TRIM56 impairs HBV infection and replication by inhibiting HBV core promoter activity.
Tian X; Dong H; Lai X; Ou G; Cao J; Shi J; Xiang C; Wang L; Zhang X; Zhang K; Song J; Deng J; Deng H; Lu S; Zhuang H; Li T; Xiang K
Antiviral Res; 2022 Nov; 207():105406. PubMed ID: 36084850
[TBL] [Abstract][Full Text] [Related]
25. Constitutive TRIM22 Expression in the Respiratory Tract Confers a Pre-Existing Defence Against Influenza A Virus Infection.
Charman M; McFarlane S; Wojtus JK; Sloan E; Dewar R; Leeming G; Al-Saadi M; Hunter L; Carroll MW; Stewart JP; Digard P; Hutchinson E; Boutell C
Front Cell Infect Microbiol; 2021; 11():689707. PubMed ID: 34621686
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the interferon-inducible p53 target gene TRIM22 (Staf50) in human T lymphocyte activation.
Obad S; Olofsson T; Mechti N; Gullberg U; Drott K
J Interferon Cytokine Res; 2007 Oct; 27(10):857-64. PubMed ID: 17970695
[TBL] [Abstract][Full Text] [Related]
27. Ancient and recent adaptive evolution in the antiviral TRIM22 gene: identification of a single-nucleotide polymorphism that impacts TRIM22 function.
Kelly JN; Woods MW; Xhiku S; Barr SD
Hum Mutat; 2014 Sep; 35(9):1072-81. PubMed ID: 24863734
[TBL] [Abstract][Full Text] [Related]
28. Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.
Li Q; Lee CH; Peters LA; Mastropaolo LA; Thoeni C; Elkadri A; Schwerd T; Zhu J; Zhang B; Zhao Y; Hao K; Dinarzo A; Hoffman G; Kidd BA; Murchie R; Al Adham Z; Guo C; Kotlarz D; Cutz E; Walters TD; Shouval DS; Curran M; Dobrin R; Brodmerkel C; Snapper SB; Klein C; Brumell JH; Hu M; Nanan R; Snanter-Nanan B; Wong M; Le Deist F; Haddad E; Roifman CM; Deslandres C; Griffiths AM; Gaskin KJ; Uhlig HH; Schadt EE; Muise AM
Gastroenterology; 2016 May; 150(5):1196-1207. PubMed ID: 26836588
[TBL] [Abstract][Full Text] [Related]
29. TRIM22 regulates macrophage autophagy and enhances Mycobacterium tuberculosis clearance by targeting the nuclear factor-multiplicity κB/beclin 1 pathway.
Lou J; Wang Y; Zheng X; Qiu W
J Cell Biochem; 2018 Nov; 119(11):8971-8980. PubMed ID: 30011088
[TBL] [Abstract][Full Text] [Related]
30. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8.
Fan L; Zhou Y; Wei X; Feng W; Guo H; Li Y; Gao X; Zhou J; Wen Y; Wu Y; Shen X; Liu L; Xu G; Zhang Z
mBio; 2024 Feb; 15(2):e0232023. PubMed ID: 38275298
[TBL] [Abstract][Full Text] [Related]
31. Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection.
Protzer U; Seyfried S; Quasdorff M; Sass G; Svorcova M; Webb D; Bohne F; Hösel M; Schirmacher P; Tiegs G
Gastroenterology; 2007 Oct; 133(4):1156-65. PubMed ID: 17919491
[TBL] [Abstract][Full Text] [Related]
32. TRIM22-Mediated Apoptosis is Associated with Bak Oligomerization in Monocytes.
Chen C; Zhao D; Fang S; Chen Q; Cheng B; Fang X; Shu Q
Sci Rep; 2017 Jan; 7():39961. PubMed ID: 28079123
[TBL] [Abstract][Full Text] [Related]
33. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
[TBL] [Abstract][Full Text] [Related]
34. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.
Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E
J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949
[TBL] [Abstract][Full Text] [Related]
35. TRIM22 inhibits the TRAF6-stimulated NF-κB pathway by targeting TAB2 for degradation.
Qiu H; Huang F; Xiao H; Sun B; Yang R
Virol Sin; 2013 Aug; 28(4):209-15. PubMed ID: 23818111
[TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of multiple TRIM proteins that inhibit hepatitis B virus transcription.
Zhang S; Guo JT; Wu JZ; Yang G
PLoS One; 2013; 8(8):e70001. PubMed ID: 23936368
[TBL] [Abstract][Full Text] [Related]
37. TRIM22 promotes the proliferation of glioblastoma cells by activating MAPK signaling and accelerating the degradation of Raf-1.
Fei X; Dou YN; Sun K; Wei J; Guo Q; Wang L; Wu X; Lv W; Jiang X; Fei Z
Exp Mol Med; 2023 Jun; 55(6):1203-1217. PubMed ID: 37258577
[TBL] [Abstract][Full Text] [Related]
38. Cytokine inhibition of the hepatitis B virus core promoter.
Romero R; Lavine JE
Hepatology; 1996 Jan; 23(1):17-23. PubMed ID: 8550037
[TBL] [Abstract][Full Text] [Related]
39. TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis.
Zhang L; Zhang B; Wei M; Xu Z; Kong W; Deng K; Xu X; Zhang L; Ζhao X; Yan L
Int J Oncol; 2020 May; 56(5):1225-1239. PubMed ID: 32319602
[TBL] [Abstract][Full Text] [Related]
40. Different subcellular localisations of TRIM22 suggest species-specific function.
Herr AM; Dressel R; Walter L
Immunogenetics; 2009 Apr; 61(4):271-80. PubMed ID: 19212762
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
